Pancreatic Cancer Research

ResearcherNingxia Medical University General HospitalActive in the last 2 years

Feng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7462-3700; OpenAlex author ID A5100431142. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Irradiation of 125I seeds blocks glycolysis in pancreatic cancer by inhibiting KLF5 m6A methylation through the suppression of RBM15. Last author DOI 10.1016/j.yexcr.2025.114538↗
  2. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer. Co-author DOI 10.3233/cbm-170231↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianjun Song · 1 shared paper, 2025 · strength 0.28
  2. Kaichun Wu · 1 shared paper, 2025 · strength 0.28
  3. Yongqiang Hua · 1 shared paper, 2017 · strength 0.07
  4. Zhouyu Ning · 1 shared paper, 2017 · strength 0.07
  5. Zhen Chen · 1 shared paper, 2017 · strength 0.07
  6. Hao Chen · 1 shared paper, 2017 · strength 0.07
  7. Peng Wang · 1 shared paper, 2017 · strength 0.07
  8. Zhiqiang Meng · 1 shared paper, 2017 · strength 0.07
  9. Luming Liu · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.